Browse

You are looking at 401 - 450 of 894 items for

  • Refine by Access: All content x
Clear All
Restricted access

Chapter 2: Converting Among Routes and Formulations of the Same Opioid

Edited by Mary Lynn McPherson

Restricted access

Chapter 3: Converting Among Routes and Formulations of Different Opioids

Edited by Mary Lynn McPherson

Restricted access

Chapter 4: Titrating Opioid Regimens: Around the Clock and to the Rescue!

Edited by Mary Lynn McPherson

Restricted access

Chapter 5: Transdermal and Parenteral Fentanyl Dosage Calculations and Conversions

Edited by Mary Lynn McPherson

Restricted access

Chapter 6: Methadone: A Complex and Challenging Analgesic, But It’s Worth It!

Edited by Mary Lynn McPherson

Restricted access

Chapter 7: Patient-Controlled Analgesia and Neuraxial Opioid Therapy

Edited by Mary Lynn McPherson

Restricted access

Chapter 8: Calculating Doses from Oral Solutions and Suspensions

Edited by Mary Lynn McPherson

Restricted access

Chapter 9: Lagniappe: A Little Something Extra in Conversion Calculations

Edited by Mary Lynn McPherson

Restricted access
Cover Demystifying Opioid Conversion Calculations

Demystifying Opioid Conversion Calculations

A Guide for Effective Dosing

Edited by Mary Lynn McPherson

Restricted access
Cover Biosimilars & Biologics

Biosimilars & Biologics

Implementation and Monitoring in a Healthcare Setting

Edited by Steven Lucio

Restricted access

Chapter 1: A New Type of Blockbuster: The Growth of Biologics

Edited by Steven Lucio

Restricted access

Chapter 10: Defining Biosimilar Value and Other Seemingly Impossible Tasks

Edited by Steven Lucio

Restricted access

Chapter 11: Biosimilar Formulary Management Strategies

Edited by Steven Lucio

Restricted access

Chapter 2: Déjà Vu or Something New?–Comparing the Generic and Biosimilar Experiences

Edited by Steven Lucio

Restricted access

Chapter 3: Bugs and Drugs, and Yeast and Mice, and Chinese Hamsters

Edited by Steven Lucio

Restricted access

Chapter 4: The $250 Billion Pyramid: Analytics in Biosimilarity Determination

Edited by Steven Lucio

Restricted access

Chapter 5: The Global Biosimilars Experience

Edited by Steven Lucio

Restricted access

Chapter 6: The American Biosimilar Experience: Red, White, and Possibly Interchangeable

Edited by Steven Lucio

Restricted access

Chapter 7: Biosimilar Clinical Trial Requirements

Edited by Steven Lucio

Restricted access

Chapter 8: Immunogenicity and Pharmacovigilance in the Biosimilar Era

Edited by Steven Lucio

Restricted access

Chapter 9: The Patent Dance and the Exclusivity Shuffle

Edited by Steven Lucio

Restricted access

Conclusion: Biosimilars 2023

Edited by Steven Lucio

Restricted access

Appendix A: Prescription and Medication Orders

Edited by Nicholas Ferencz

Restricted access
Cover Basic Concepts in Medicinal Chemistry

Basic Concepts in Medicinal Chemistry

Edited by Marc W. Harrold and Robin M. Zavod

Restricted access

Chapter 1: Competence Assessment

Lee B. Murdaugh

Restricted access

Chapter 1: Introduction

Edited by Marc W. Harrold and Robin M. Zavod

Restricted access

Chapter 10: Orientation Record

Edited by Lee B. Murdaugh

Restricted access

Chapter 10: Whole Molecule Drug Evaluation

Edited by Marc W. Harrold and Robin M. Zavod

Restricted access

Chapter 11: Initial Skills Assessment—General

Edited by Lee B. Murdaugh

Restricted access

Chapter 12: Initial Skills Assessment—Pharmacist

Edited by Lee B. Murdaugh

Restricted access

Chapter 13: Initial Skills Assessment—Pharmacy Technician

Edited by Lee B. Murdaugh

Restricted access

Chapter 14: Confidentiality and Patient Rights

Gary G. Cacciatore

Restricted access

Chapter 15: Safety

Edited by Lee B. Murdaugh

Restricted access

Chapter 16: Security

Edited by Lee B. Murdaugh

Restricted access

Chapter 17: Fire Safety

Edited by Lee B. Murdaugh

Restricted access

Chapter 18: Hazardous Materials

Lee B. Murdaugh

Restricted access

Chapter 19: Emergency Management

Lee B. Murdaugh

Restricted access

Chapter 2: Designing and Managing a Competence Assessment Program

Lee B. Murdaugh and Angela K. Gomez

Restricted access

Chapter 2: Functional Group Characteristics and Roles

Edited by Marc W. Harrold and Robin M. Zavod

Restricted access

Chapter 20: Infection Prevention

Lee B. Murdaugh

Restricted access

Chapter 21: Information Management

Edited by Lee B. Murdaugh

Restricted access

Chapter 22: Neonatal and Infant Patients for Pharmacists

Chrissy Schabacker

Restricted access

Chapter 23: Pediatric and Adolescent Patients for Pharmacists

Chrissy Schabacker

Restricted access

Chapter 24: Adult Patients for Pharmacists

Nisha Pherwani

Restricted access

Chapter 25: Geriatric Patients for Pharmacists

Charlie Waters

Restricted access

Chapter 26: Obstetric Patients

Kenneth J. Knapp

Restricted access

Chapter 27: Oncology Patients

Nisha Pherwani

Restricted access

Chapter 28: Psychiatric Patients

Talia Puzantian

Restricted access

Chapter 29: Medication Dosing in Patients with Renal Dysfunction

Curt W. Quap

Restricted access

Chapter 3: Educating the Pharmacy Staff

Angela K. Gomez